NCT04550312

Brief Summary

The increase of all-cause mortality in the areas with high COVID-19 transmission rate due to COVID-19 deaths and the collateral damage to other healthcare problems is well known. However, the COVID-19 mortality is very low in the regions with low transmission rate and sufficient medical resources. In such regions, strict prevention measures were taken and these would alter the people's lifestyle and hygienic habits and further impact on non-COVID-19 deaths. Yet, there has no thorough investigation in this aspect.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

September 13, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 16, 2020

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

September 16, 2020

Status Verified

September 1, 2020

Enrollment Period

1 month

First QC Date

September 13, 2020

Last Update Submit

September 13, 2020

Conditions

Lifestyle AlterationNon-COVID Deaths

Outcome Measures

Primary Outcomes (1)

  • Numeric values of all-cause death and the death rates of non-COVID diseases

    from January 2018 to June 2020

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

all cases of non-Covid-19 deaths in Xuzhou region between 2018 and 2020

You may qualify if:

  • All cases of death reported to the Xuzhou CDC during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xuzhou Medical University affiliated Hospital

Xuzhou, Jiangsu, 221000, China

RECRUITING

Study Officials

  • minglong chen, PHD

    Xuzhou Medical University affiliated hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

ming chu, PHD

CONTACT

86-2568136965chuming@njmu.edu.cn

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2020

First Posted

September 16, 2020

Study Start

September 1, 2020

Primary Completion

October 1, 2020

Study Completion

October 1, 2020

Last Updated

September 16, 2020

Record last verified: 2020-09

Locations

CN(1)